170646 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes Hydrolases (3)
Sub-classes:DETECTING CANCER
#2METHODS AND COMPOUNDS MODIFYING MITOCHONDRIAL FUNCTION
#3SYSTEMS AND METHOD FOR TARGET ENGAGEMENT
#4BIOMARKERS IN LONG-COVID-19
#5NEW SYNTHETIC DRUGS FOR TREATING ALZHEIMER'S DISEASE
#6RAS BIOSENSORS
#7RATIO BETWEEN LTA4H AND METRNL IN THE ASSESSMENT OF POLYCYSTIC OVARIAN SYNDROME
#8LEUKOTRIENE A4 HYDROLASE (LTA4H) AS (BLOOD) BIOMARKER FOR THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME
#9CIRCULARLY PERMUTATED HALOALKANE TRANSFERASE FUSION MOLECULES
#10INTRACELLULAR LIGATION OF PHOTOCATALYSTS FOR PHOTO-RESPONSIVE, PROBE-MEDIATED PROTEIN LABELING
#11SPATIAL MRNA/PROTEIN CO-ASSAYS USING APTAMERS
#12T Cell Receptor Identification
#13ANTI-MUTATED KRAS T CELL RECEPTORS
#14IDENTIFYING DISEASE-CAUSING HUMAN DDX41 GENETIC VARIANTS
#15ANTI-HELICASE THERAPY FOR TREATMENT OF REPEAT EXPANSION DISEASE
#16COMPOUNDS, COMPOSITIONS, AND METHODS FOR CELL-SPECIFIC PHARMACOLOGY
#17REPORTER CELL FOR ASSESSING DDX3 HELICASE ACTIVITY
#18ENHANCEMENT OF KINASE TARGET ENGAGEMENT
#19RAN PROTEINS IN SPORADIC AMYOTROPHIC LATERAL SCLEROSIS
#20METHOD FOR MAINTAINING NANOPORE SEQUENCING SPEED
#21HELICASE BCH2X AND USE THEREOF
#22COMPOSITIONS AND METHODS FOR PREDICTING THERAPEUTIC OUTCOME
#23COMPOSITIONS AND METHODS FOR DIAGNOSING AND/OR TREATING CHRONIC KIDNEY DISEASE
#24A METHOD FOR DETECTING CLUSTERING OF RAS PROTEIN
#25METHODS FOR AIDING IN THE DETERMINATION OF WHETHER TO PERFORM IMAGING ON A HUMAN SUBJECT WHO HAS SUSTAINED OR MAY HAVE SUSTAINED AN INJURY TO THE HEAD USING EARLY BIOMARKERS
#26SYSTEMS AND METHODS FOR PREDICTING RESPONSE TO ORAL MINOXIDIL FOR THE TREATMENT OF ANDROGENETIC ALOPECIA
#27METHODS FOR MEASURING UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 LEVELS IN BLOOD
#28OFF THE SHELF PROXIMITY BIOTINYLATION ENZYME
#29TETRAZOLIUM-BASED COLORIMETRIC ASSAY
#30Methods for the Treatment of Fibrotic Disease
#31Cilia Protein as Biomarkers and Methods of Use
#32T-TYPE CALCIUM CHANNEL ANTAGONISTS AND USES THEREOF
#33Method to Evaluate the Capability of Compounds on the Trapping of Proteins
#34METHOD OF DETERMINING VIRAL INFECTION
#35METHODS OF DETERMINING RISK OF AND TREATING CANCER RECURRENCE
#36DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF CENTRONUCLEAR MYOPATHIES
#37METHODS OF EVALUATING BRAIN INJURY IN A PEDIATRIC SUBJECT
#38Biomarker for diagnosing rheumatoid arthritis and uses thereof
#39METHODS AND COMPOUNDS MODIFYING MITOCHONDRIAL FUNCTION
#40COMPOSITIONS AND METHODS TARGETING THE NUCLEOTIDE FREE STATE OF RAS TO BLOCK ONCOGENIC SIGNALING AND TRANSFORMATION
#41A SMALL MOLECULE THERAPEUTIC FOR PARKINSON'S DISEASE PAIRED WITH A BIOMARKER OF THERAPEUTIC ACTIVITY
#42METHODS FOR TREATING RAN PROTEIN-ASSOCIATED NEUROLOGICAL DISEASES
#43APTAMER SPECIFICALLY BINDING TO KRAS PROTEIN AND METHOD FOR USING SAME
#44Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
#45METHODS AND SYSTEMS FOR IDENTIFYING MODULATORS OF PERVASIVE DEVELOPMENTAL DISORDERS
#46Methods for measuring ubiquitin carboxy—terminal hydrolase L1 levels in blood
#47TREATMENT STRATIFICATION FOR AN EXACERBATION OF INFLAMMATION
#48KRAS SPECIFIC ANTIBODIES AND USES THEREOF
#49METHOD FOR IDENTIFYING MODULATORS OF G3BP ACTIVITY
#50Anti-mutated KRAS T cell receptors
#51METHODS AND COMPOSITIONS COMPRISING REDUCED LEVEL OF HOST CELL PROTEINS
#52ENHANCEMENT OF KINASE TARGET ENGAGEMENT
#53Compositions and methods for predicting therapeutic outcome
#54INHIBITION AND TREATMENT OF GASTROINTESTINAL BIOFILMS
#55Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections
#56Method of screening ATP11C or CDC50A inhibitor
#57COMPOSITIONS AND METHODS FOR TREATMENT OF LUNG FUNCTION
#58Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
#59Subject anti-HCV antibody detection assays employing NS3 capture peptides
#60BRET SENSOR MOLECULES FOR DETECTING HYDROLASES
#61Method for identifying modulators of G3BP activity
#62SIGNATURES AND DETERMINANTS FOR DISTINGUISHING BETWEEN A BACTERIAL AND VIRAL INFECTION AND METHODS OF USE THEREOF
#63Targeted antimicrobials and related compositions, methods and systems
#64Yeast-based immunotherapy and type I interferon sensitivity
#65COMPOSITIONS AND METHODS FOR TREATMENT OF LUNG FUNCTION
#66Dynamin 2 inhibitor for the treatment of centronuclear myopathies
#67System and method for detecting a periprosthetic infection
#68Methods for detecting Na/K-ATPase-mediated Src signaling for diagnosis and prognosis of cancer
#69Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
#70ASSAY
#71Transmembrane nanopore with nucleic acid unwinding function and its construction methods and applications
#72Method and Device for Combined Detection of Viral and Bacterial Infections
#73DDX43 AS A BIOMARKER OF RESISTANCE TO MEK1/2 INHIBITORS
#74Quantifying KRAS for Optimal Cancer Therapy
#75Disruption of EGFR-SAR1 interaction for cancer treatment
#76COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#77Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections
#78Method of screening ATP11C or CDC50A inhibitor
#79Method for obtaining female germline stem cells from follicular aspirates
#80Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
#81Cancer biomarker and diagnostic
#82Subject anti-HCV antibody detection assays employing NS3 capture peptides
#83Sumoylation of Serca2A and Cardiovascular Disease
#84Diagnostic method
#85Biomarkers of Response to Inhibition of Poly-ADP Ribose Polymerase (PARP) in Cancer
#86Methods for measuring ubiquitin carboxy-terminal hydrolase L1 levels in blood
#87Cyclic peptide binder against oncogenic K-Ras
#88COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#89Markers for inflammatory bowel disease
#90Compositions and methods for treatment of lung function
#91BIOMARKERS ASSOCIATED WITH BRM INHIBITION
#92Inhibition and treatment of gastrointestinal biofilms
#93USE OF CYP EXPRESSION TO DIRECT THERAPEUTIC INTERVENTION IN CANCER
#94Autoantigens for diagnosis of rheumatoid arthritis
#95ANTI-VASA ANTIBODIES, AND METHODS OF PRODUCTION AND USE THEREOF
#96Inhibitors of mitochondrial fission and methods of use thereof
#97Method for determining the survival prognosis of a patient suffering from pancreatic cancer
#98SIGNATURES AND DETERMINANTS FOR DISTINGUISHING BETWEEN A BACTERIAL AND VIRAL INFECTION AND METHODS OF USE THEREOF
#99Interaction of methylated LSD1 and CHD1, a compound inhibiting this interaction for use in therapy, and a screening method for such a compound
#100Identification of a 5-Gene Expression Signature Predicting Clinical Outcome of Patients with Brain Tumors
#101Lateral flow device and method of use
#102Biomarkers of Response to Inhibition of Poly-ADP Ribose Polymerase (PARP) in Cancer
#103NRAS related cancer therapy
#104COMPOSITIONS FOR INCREASING SURVIVAL OF MOTOR NEURON PROTEIN (SMN) LEVELS IN TARGET CELLS AND METHODS OF USE THEREOF FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY
#105Compounds and methods for the treatment of drug resistance in cancer cells against paclitaxel
#106Methods for modulating ATRX-dependent gene repression
#107Inhibitors of mitochondrial fission and methods of use thereof
#108Kit comprising ATP-diphosphohydrolase for detecting bacterial ATP in a sample
#109Anti-mutated KRAS T cell receptors
#110Crystal structures of human Torsin-A and methods of determining and using the same
#111Markers for inflammatory bowel disease
#112Use of DDX3X inhibitors for the treatment of pneumovirus infections
#113Method for inhibiting intracellular activated RAS using intact immunoglobulin-type antibody having cytosol-penetrating ability and use thereof
#114METHOD OF DETECTING HELICASE ACTIVITY
#115SRM/MRM Assay for the GTPase KRas Protein (KRas)
#116Covalent tethering of functional groups to proteins and substrates therefor
#117Method of treatment employing cardiac glycoside
#118Yeast-based immunotherapy and type I interferon sensitivity
#119Method of screening ATP11C or CDC50A inhibitor
#120Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
#121ASYMMETRIC INTERFERING RNA COMPOSITIONS THAT SILENCE K-RAS AND METHODS OF USES THEREOF
#122Sumoylation of SERCA2a and cardiovascular disease
#123TREATMENT OF NEURODEGENERATIVE AND NEURODEVELOPMENTAL DISEASES BY INHIBITION OF THE a2-Na/K ATPase/a-ADDUCIN COMPLEX
#124HCV antigen-antibody combination assay and methods and compositions for use therein
#125Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements
#126DDX3 AS A BIOMARKER FOR CANCER AND METHODS RELATED THERETO
#127Anti-vasa antibodies, and methods of production and use thereof
#128ASSAYS AND METHODS FOR CELL PROLIFERATION-TARGETED TREATMENT THERAPIES
#129PROTEIN STRUCTURAL BIOMARKERS TO GUIDE TARGETED CHEMOTHERAPIES
#130Biomarkers for Ovarian Cancer
#131Method and device for combined detection of viral and bacterial infections
#132Dynamin 2 inhibitor for the treatment of centronuclear myopathies
#133Cyclic peptide binder against oncogenic K-Ras
#134DDX43 as a biomarker of resistance to MEK1/2 inhibitors
#135ATRX AS A COMPANION DIAGNOSTIC FOR CDK4 INHIBITORS
#136Cancer biomarker and diagnostic
#137Compounds and methods for inhibiting Cif virulence factor
#138ACYL PIPERIDINE INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE
#139Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
#140Assays for screening for or identifying an agent or molecule that can block or inhibit AVB3 integrin from forming a complex with KRAS
#141Biomarkers of Response to Inhibition of Poly-ADP Ribose Polymerase (PARP) in Cancer
#142Subject anti-HCV antibody detection assays employing NS3 capture peptides
#143METHOD FOR PREDICTING RESPONSE TO CANCER TREATMENT
#144HCV ANTIGEN-ANTIBODY COMBINATION ASSAY AND METHODS AND COMPOSITIONS FOR USE THEREIN
#145Inhibitors of mitochondrial fission and methods of use thereof
#146METHODS FOR DRUG DISCOVERY
#147KRAS MUTATIONS AND RESISTANCE TO ANTI-EGFR TREATMENT
#148Method and device for combined detection of viral and bacterial infections
#149Biomarkers associated with BRM inhibition
#150Preparations and methods for treating malignancies
#151Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition
#152Aminoheteroaryl compounds as MTH1 inhibitors
#153Methods and compositions for inducing apoptosis by stimulating ER stress
#154Autoantibody Signature for the Early Detection of Ovarian Cancer
#155Diagnosis of a neurological disease
#156Competition based-detection assays
#157Prodrugs of Modulators of ABC Transporters
#158Identification of a 5-Gene Expression Signature Predicting Clinical Outcome of Patients with Brain Tumors
#159Sumoylation of SERCA2a and Cardiovascular Disease
#160Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside
#161IDENTIFICATION OF THE DCPS GENE ON 11Q24.2, WHICH ENCODES THE HUMAN DECAPPING ENZYME SCAVENGER, IN NON-SYNDROMIC AUTOSOMAL RECESSIVE MENTAL RETARDATION, DIAGNOSTIC PROBES THEREOF AND METHODS OF IDENTIFYING SUBJECTS WITH SAME
#162CELL LINES EXPRESSING CFTR AND METHODS OF USING THEM
#163Methods for Cancer Diagnosis, Anti-Cancer Drug Screening, and Test of Drug Effectiveness on the Basis of Phoshorylation of Ras at Thr-144 and Thr-148
#164Multiple targeted RNAI for the treatment of cancers
#165CANCER DIAGNOSTIC AND THERAPEUTIC METHOD TARGETING MOLECULES EXPRESSED IN CANCER STEM CELLS
#166Rejuvenation of precursor cells
#167Photocleavable linker
#168Methods for identifying candidates for the treatment of neurodegenerative diseases
#169Heteroaryl derivatives as CFTR modulators
#170METHODS FOR IDENTIFYING ANTI-CANCER COMPOUNDS
#171Methods and compositions for modulating G-alpha-Q signaling
#172PREDICTING BLADDER CANCER RESPONSIVENESS TO BCG
#173Compositions Comprising RAC Mutants, and Methods of Use Thereof
#174Methods for identifying and treating cancer patients
#175DETERMINING SENSITIVITY OF CELLS TO B-RAF INHIBITOR TREATMENT BY DETECTING KRAS MUTATION AND RTK EXPRESSION LEVELS
#176Treatment of acute myeloid leukemia and myelodysplastic syndromes
#177Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator
#178Assay for identification of therapeutics targeting ternary complex formation in protein synthesis
#179Breast cancer assay
#180Methods of treating a meiotic kinesin-associated disease
#181Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
#182Method and device for combined detection of viral and bacterial infections
#183URINARY BIOMARKERS OF RENAL AND MITOCHONDRIAL DYSFUNCTION
#184Polypeptides containing a modified fragment of the peptide IF1
#185Method to prevent cancer metastasis and inhibit inflammation by inhibition of p68 interaction with calmodulin
#186Method for sorting of pluripotent cells
#187COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#188System and method for determining individualized medical intervention for a disease state
#189System and method for determining individualized medical intervention for a disease state
#190Targeted antimicrobials and related compositions, methods and systems
#191Enzymatic biosensing systems
#192Activation of sodium potassium ATPase
#193Method of producing a positive inotropic effect using an antibody that binds sodium potassium atpase
#194Agents and methods related to screening for resistance to DR5 and reducing resistance to DR5 agonists
#195Method and device for combined detection of viral and bacterial infections
#196Phosphatase coupled glycosyltransferase assay
#197GENETIC POLYMORPHISMS ASSOCIATED WITH CORONARY EVENTS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF
#198Inhibitors of mitochondrial fission and methods of use thereof
#199ANALYTICAL APPLICATIONS OF ENZYMATIC GROWTH OF FLUORESCENT QUANTUM DOTS
#200Heteroaryl derivatives as CFTR modulators
#201Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator
#202Covalent tethering of functional groups to proteins and substrates therefor
#203DETERMINING SENSITIVITY OF CELLS TO B-RAF INHIBITOR TREATMENT BY DETECTING KRAS MUTATION AND RTK EXPRESSION LEVELS
#204Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
#205Protein structural biomarkers to guide targeted chemotherapies
#206Lipoprotein lipase assay
#207CELL LINES EXPRESSING CFTR AND METHODS OF USING THEM
#208Fluorescence resonance energy transfer assays for sarco/endoplasmic reticulum calcium atpase and phospholamban
#209Antibodies that bind alpha subunit of sodium potassium ATPase
#210Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof
#211Methods and compositions for inducing apoptosis by stimulating ER stress
#212Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
#213Genetically engineered G-alpha proteins and uses thereof
#214AGENT THAT MODULATES PHYSIOLOGICAL CONDITION OF PESTS, INVOLVED IN INSECT VESICLE-FUSING ATPASE ACTIVITY
#215Methods of treating a meiotic kinesin associated disease
#216Methods for Cancer Diagnosis, Anti-Cancer Drug Screening, and Test of Drug Effectiveness on the Basis of Phoshorylation of Ras at Thr-144 and Thr-148
#217Covalent tethering of functional groups to proteins and substrates therefor
#218CENTROSOME-ASSAY
#219PROCESS TO DIAGNOSE OR TREAT BRAIN INJURY
#220Targeted antimicrobials and related compositions, methods and systems
#221Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside
#222Method and device for combined detection of viral and bacterial infections
#223HADHs as Modifiers of the p21 Pathway and Methods of Use
#224Fluorescently labeled fusion protein for assaying adenosine triphosphate
#225Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
#226Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
#227COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#228Modulators of the transporter ABCD3 for treating acne or hyperseborrhea
#229Method of identifying compounds useful to treat neuronal degenerative diseases
#230Heteroaryl derivatives as CFTR modulators
#231THREE-DIMENSIONAL STRUCTURE OF A DNAB-FAMILY REPLICATIVE HELICASE (G40P), USES THEREOF, AND METHODS FOR DEVELOPING ANTI-BACTERIAL PATHOGENS BY INHIBITING DNAB HELICASES AND THE INTERACTIONS OF DNAB HELICASE WITH PRIMASE
#232Regulation of F-ATPase beta subunit cellular location
#233INHIBITION AND TREATMENT OF GASTROINTESTINAL BIOFILMS
#234Prodrugs of modulators of ABC transporters
#235Methods and compositions for including apoptosis by stimulating ER stress
#236NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#237Enzymatic biosensors with enhanced activity retention for detection of organic compounds
#238High throughput sarcomeric assay
#239Process for microbial production of a valuable compound
#240Diagnostic and Therapeutic use of a Plasma Membrane Atpase
#241Polynucleotides encoding proteins for covalent tethering to functional groups and substrates
#242Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
#243Method of identifying compounds useful to treat neuronal degenerative diseases
#244Methods for screening and therapeutic applications of kinesin modulators
#245Methods and Compounds for Treating Inflammation
#246Methods and Composition for Diagnosing and Treating Cancer
#247Assays for detecting modulators of cytoskeletal function
#248Biosensor
#249System and method for determining individualized medical intervention for a disease state
#250METHOD OF IDENTIFYING COMPOUNDS USEFUL TO TREAT NEURONAL DEGENERATIVE DISEASES
#251High throughput sarcomeric assay
#252Hydrolytic substrates for an analyte-dependent enzyme activation system
#253Method for cancer detection, progression analysis and malign tumour prognosis based on the study of metabolic markers of the cell
#254CD39L3 and its role in diabetes
#255Elisa method for the detection of guanylate binding protein 1 (gbp-1)
#256Method for identifying kinesin inhibitors
#257Therapeutic and prophylactic agents and methods of using the same
#258Covalent tethering of functional groups to proteins and substrates therefor
#259Method for quantitatively determining cholesterol in high density lipoproteins and reagents therefor
#260Method and reagent for measuring cholesterol in high-density lipoproteins
#261Methods for treating congestive heart failure
#262Method of judging viral infection
#263HADHs as modifiers of the p21 pathway and methods of use
#264HADHs as modifiers of the p21 pathway and methods of use
#265Immunocapture of mitochondrial protein complexes
#266Methods and compositions for treating and preventing autoimmune disorders
#267Method for patient stratification and drug efficacy monitoring
#268Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections